The use of serum methadone levels in patients receiving methadone maintenance

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Clinical pharmacology and therapy

• Publication date

  1988-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1988.86PMID 3378383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain

  1987cited by this paper
• Prediction of methadone clearance from patient characteristics

  1987cited by this paper
• Chronic heroin use during methadone treatment: a test of the efficacy of high maintenance doses.

  1984cited by this paper
• Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.

  1984cited by this paper
• Single‐day methadone dose alteration: Detectability and symptoms

  1984cited by this paper
• Factors modifying the pharmacological effectiveness of methadone.: (471722004-001)

  1983cited by this paper
• Methadone maintenance dosage levels and program retention.

  1982cited by this paper
• Phenytoin-induced methadone withdrawal.

  1981cited by this paper
• Addictive behavior.

  1980cited by this paper
• Serum methadone as an aid in managing methadone maintenance patients.

  1978cited by this paper
• Methadone maintenance: Plasma levels and therapeutic outcome

  1978cited by this paper
• DRUG INTERACTIONS WITH METHADONE *

  1976cited by this paper
• Methadyl acetate and methadone as maintenance treatments for heroin addicts. A veterans administration cooperative study.

  1976cited by this paper
• Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride

  1975cited by this paper
• Methadone in man: Pharmacokinetic and excretion studies in acute and chronic treatment

  1975cited by this paper
• Control of methadone dosage by patients.

  1975cited by this paper

• Buprenorphine and methadone differentially alter early brain development in human cortical organoids.

  2023cites this paper
• Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat.

  2023cites this paper
• Analgesics

  2022cites this paper
• A review on advances in the development of electrochemical sensors for the detection of anesthetic drugs.

  2022cites this paper
• What the lab can and cannot do: clinical interpretation of drug testing results

  2020cites this paper
• Long QTc During Methadone Maintenance: Contributors and Interventions Over 4 Years.

  2017cites this paper
• Methadone Concentrations in Exhaled Breath Condensate, Serum and Urine of Patients Under Maintenance Treatment

  2017cites this paper
• Pharmacogenetics of Methadone Response

  2017cites this paper
• Pharmacotherapy in Methadone Maintenance: Clinical Utility of Peak-Trough Blood Levels

  2016cites this paper
• Narcotic Analgesics and Common Drugs of Abuse: Clinical Correlations and Laboratory Assessment.

  2016cites this paper
• In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis

  2015cites this paper
• Intérêt de la détermination de la méthadonémie dans l'ajustement thérapeutique du traitement substitutif par chlorhydrate de méthadone

  2013cites this paper
• Opioids and Opiates

  2012cites this paper
• Neuropsychological function as a result of chronic exposure to methadone and other opioids

  2012cites this paper
• A Randomized Double-Blind Placebo Controlled Study of Methadone and Diazepam with or without Carbamazepine for Combined Opioid and Benzodiazepine Detoxification

  2012cites this paper
• Toxicology and Therapeutic Drug Monitoring

  2011cites this paper
• Methadone: a review of drug-drug and pathophysiological interactions

  2011cites this paper
• Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships of Methadone in a Sample of Iranian (Mazandarani) Opiate Users Undergoing Methadone Maintenance Treatment

  2011cites this paper
• Evaluation of methadone absorption after topical administration to hospice patients.

  2011cites this paper
• Case Report: Methadone Maintenance Dose of 1200 mg/day in an Ultra‐rapid Metabolizer

  2010cites this paper
• Review of methadone treatment in Australia

  2009cites this paper
• Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment

  2006cites this paper
• Therapeutic thresholds in methadone maintenance treatment: a receiver operating characteristic analysis.

  2006cites this paper
• Stereoselective determination of methadone and its main metabolite in serum and urine from methadone maintenance patients.

  2006cites this paper
• An examination of the pharmacodynamics and pharmacokinetics of Levo-alpha-acetylmethadol ( LAAM ), compared to methadone, in opioid maintenance patients

  2006cites this paper
• Methadone maintenance treatment: An update

  2005cites this paper
• Psychophysiological reactions in methadone maintenance patients do not correlate with methadone plasma levels

  2005cites this paper
• Steady-state pharmacokinetics of methadone in opioid addicts

  2004cites this paper
• Fluvoxamine as an Adjunct to Promote Methadone Dose Optimization

  2003cites this paper
• The pharmacokinetics of methadone in healthy subjects and opiate users.

  2003cites this paper
• Methadone Drug Interactions

  2003cites this paper
• Conservative management with naltrexone of an iatrogenic methadone overdose in an opiate-naive patient.

  2002cites this paper
• Interindividual Variability of the Clinical Pharmacokinetics of Methadone

  2002cites this paper
• Implementation of a clinic policy of client-regulated methadone dosing.

  2001cites this paper
• The Relationship Between Mood State and Plasma Methadone Concentration in Maintenance Patients

  2001cites this paper
• The effect of tobacco smoking on subjective symptoms of inadequacy (“not holding”) of methadone dose among opiate addicts in methadone maintenance treatment

  2001cites this paper
• Relevante Wechselwirkungen von (Ko-) Analgetika mit anderen häufig in der Onkologie angewandten Substanzen

  2000cites this paper
• Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome.

  2000cites this paper
• Letter to the Editor: On the Usefulness of Therapeutic Drug Monitoring of Methadone

  2000cites this paper
• Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment.

  2000cites this paper
• Programa de mantenimiento con metadona (PMM) en prisión: Cambios sociales y sanitarios

  2000cites this paper
• Steady‐state pharmacokinetics and pharmacodynamics in methadone maintenance patients: Comparison of those who do and do not experience withdrawal and concentration‐effect relationships

  1999cites this paper
• Optimizing response to methadone maintenance treatment: use of higher-dose methadone.

  1999cites this paper
• Therapeutic Drug Monitoring for Methadone: Scanning the Horizon

  1999cites this paper
• Methadone is poorly removed by haemodialysis.

  1999cites this paper
• Novel high-performance liquid chromatographic and solid-phase extraction methods for quantitating methadone and its metabolite in spiked human urine.

  1999cites this paper
• A therapeutic use of the methadone fluvoxamine drug interaction.

  1999cites this paper
• Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment

  1999influential citation
• Opioid Drug-Drug Interactions: A Review

  1998cites this paper
• Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.

  1998cites this paper
• Patterns of symptom complaints in methadone maintenance patients.

  1997cites this paper
• Early Recurrence of Withdrawal Symptoms under Phenytoin and Chronic Alcohol Use

  1997cites this paper
• Enantioselective high-performance liquid chromatography determination of methadone enantiomers and its major metabolite in human biological fluids using a new derivatized cyclodextrin-bonded phase.

  1997cites this paper
• Screening for Drugs of Abuse (II): Cannabinoids, Lysergic Acid Diethylamide, Buprenorphine, Methadone, Barbiturates, Benzodiazepines and other Drugs

  1997cites this paper
• Safety Considerations in the Use of Drug Combinations During General Anaesthesia

  1997cites this paper
• [Determination of serum methadone with an immunologic kit and comparison with a liquid chromatography method].

  1996cites this paper
• Influence of Plasma‐protein Binding on Analgesic Effect of Methadone in Rats with Spontaneous Withdrawal

  1996cites this paper
• Opiate-dependent patients receiving methadone. How physicians should manage therapy.

  1996cites this paper
• Patterns of Craving and Pharmacokinetics in Long-Term Opiate Addicts in Methadone Maintenance Therapy

  1996cites this paper
• The Determination of Methadone and Metabolites in Human Urine by HPLC with Ultraviolet, and Particle Beam Mass Spectrometric Detection

  1994cites this paper
• Drug Interactions of Clinical Significance with Opioid Analgesics

  1993cites this paper
• [Individual dosing in methadone substitution therapy. Determination of concentration with high performance liquid chromatography in comparison to immunoassay].

  1992cites this paper
• Plasma methadone measurements and their role in methadone detoxification programs.

  1992cites this paper
• PlasmaMethadoneMeasurementsand Their Role in MethadoneDetoxification Programs

  1992cites this paper
• The use of plasma levels to optimize methadone maintenance treatment.

  1992cites this paper
• High-DoseMethadoneand the Need for DrugMeasurementsin Plasma

  1991cites this paper
• Chiral analysis of methadone in plasma by high-performance liquid chromatography.

  1991cites this paper
• High-dose methadone and the need for drug measurements in plasma.

  1991cites this paper
• Pharmacologic Interventions for the Treatment of Opioid Dependence and Withdrawal

  1990cites this paper
• Monitoring of Plasma Methadone: Intercorrelation Between Immunoassay and Gas Chromatography‐Mass Spectrometry

  1990cites this paper
• Serum levels of methadone in maintenance clients who persist in illicit drug use.

  1990cites this paper
• Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases.

  1989cites this paper
• Methadone and theories of addiction.

  1989cites this paper